CLINICAL_TRIALS
trial_result
· 2020-03-16
Clinical Trial Update: Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics [Phase 4]
Summary
Phase 4 clinical trial investigating how gender and HIV infection influence the pharmacokinetics of zidovudine and lamivudine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2020-03-16